Atrish Bagchi, Ph.D.
Affiliations: | 2018 | Center for Cellular Immunotherapies | University of Pennsylvania, Philadelphia, PA, United States |
| 2018- | University of Toronto, Toronto, ON, Canada |
Area:
Cancer Immunotherapy, Structural Biology, EGFR, Antibody DrugGoogle:
"Atrish Bagchi"Cross-listing: Chemistry Tree
Parents
Sign in to add mentor| Kathryn M. Ferguson | grad student | 2012-2016 | University of Pennsylvania School of Medicine |
| Michael C. Milone | post-doc | 2016- | University of Pennsylvania Perelman School of Medicine (Chemistry Tree) |
| Sachdev Sidhu | post-doc | 2018- | (Chemistry Tree) |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Grover P, Nunez-Cruz S, Leferovich J, et al. (2023) F77 antigen is a promising target for adoptive T cell therapy of prostate cancer. Biochemical and Biophysical Research Communications. 680: 51-60 |
| Bagchi A, Haidar JN, Eastman SW, et al. (2017) Molecular basis for necitumumab inhibition of EGFR variants associated with acquired cetuximab resistance. Molecular Cancer Therapeutics |
| Ganetzky R, Finn E, Bagchi A, et al. (2015) EGFR mutations cause a lethal syndrome of epithelial dysfunction with progeroid features. Molecular Genetics & Genomic Medicine. 3: 452-8 |
| Bessman NJ, Bagchi A, Ferguson KM, et al. (2014) Complex relationship between ligand binding and dimerization in the epidermal growth factor receptor. Cell Reports. 9: 1306-17 |
| Bagchi A, Bessman NJ, Wu NZ, et al. (2014) Allosteric Regulation of the Epidermal Growth Factor Receptor Biophysical Journal. 106: 105a |
| Schmitz KR, Bagchi A, Roovers RC, et al. (2013) Structural evaluation of EGFR inhibition mechanisms for nanobodies/VHH domains. Structure (London, England : 1993). 21: 1214-24 |